Abbott Laboratories Company Profile (NYSE:ABT)

About Abbott Laboratories

Abbott Laboratories logoAbbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a line of healthcare products. The Company operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products. Its Established Pharmaceutical Products segment's therapeutic area portfolio of products includes gastroenterology products, women's health products, and respiratory drugs and vaccines.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: ABT
  • CUSIP: 00282410
Key Metrics:
  • Previous Close: $40.74
  • 50 Day Moving Average: $41.66
  • 200 Day Moving Average: $41.34
  • 52-Week Range: $1,469,995,000.00 - $36.00
  • Trailing P/E Ratio: 26.73
  • Foreward P/E Ratio: 16.53
  • P/E Growth: 2.00
  • Market Cap: $59.53B
  • Outstanding Shares: 1,469,995,000
  • Beta: 0.87
  • Net Margins: 6.61%
  • Return on Equity: 15.45%
  • Return on Assets: 8.06%
  • Debt-to-Equity Ratio: 0.29%
  • Current Ratio: 1.50%
  • Quick Ratio: 1.17%
Additional Links:
Companies Related to Abbott Laboratories:

Analyst Ratings

Consensus Ratings for Abbott Laboratories (NYSE:ABT) (?)
Ratings Breakdown: 6 Hold Ratings, 15 Buy Ratings
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $46.79 (15.52% upside)

Analysts' Ratings History for Abbott Laboratories (NYSE:ABT)
DateFirmActionRatingPrice TargetDetails
9/19/2016Bank of America Corp.Reiterated RatingBuyView Rating Details
9/19/2016Royal Bank Of CanadaReiterated RatingOutperform$48.00View Rating Details
9/13/2016Jefferies GroupLower Price TargetBuy$52.00 -> $48.00View Rating Details
8/10/2016BTIG ResearchReiterated RatingBuy$45.00View Rating Details
8/9/2016Deutsche Bank AGReiterated RatingBuyView Rating Details
7/28/2016ArgusReiterated RatingBuy$55.00View Rating Details
7/21/2016Barclays PLCBoost Price TargetOverweight$48.00 -> $50.00View Rating Details
6/21/2016Edward JonesUpgradeHold -> BuyView Rating Details
6/8/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details
5/12/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details
5/2/2016BMO Capital MarketsReiterated RatingBuyView Rating Details
4/30/2016S&P Equity ResearchReiterated RatingHoldView Rating Details
4/30/2016GabelliReiterated RatingBuyView Rating Details
4/28/2016Piper Jaffray Cos.DowngradeOverweight -> NeutralView Rating Details
4/21/2016Cowen and CompanyReiterated RatingNeutral -> Buy$44.00 -> $48.00View Rating Details
4/14/2016First GlobalDowngradeOutperform -> MarketperformView Rating Details
3/28/2016Stifel NicolausBoost Price TargetBuy$42.00 -> $47.00View Rating Details
3/28/2016Leerink SwannBoost Price TargetMarket Perform$37.00 -> $40.00View Rating Details
1/29/2016Raymond James Financial Inc.Lower Price TargetOutperform$46.00 -> $42.00View Rating Details
1/29/2016Goldman Sachs Group Inc.Lower Price TargetNeutral$44.00 -> $40.00View Rating Details
1/29/2016William BlairDowngradeOutperform -> Market PerformView Rating Details
1/4/2016Morgan StanleyDowngradeOverweight -> Equal Weight$50.00View Rating Details
5/27/2015Evercore Partners Inc.Initiated CoverageBuy$54.00View Rating Details
5/26/2015Evercore ISIInitiated CoverageBuy$54.00View Rating Details
4/23/2015JPMorgan Chase & Co.Boost Price TargetNeutral$46.00 -> $48.00View Rating Details
(Data available from 10/23/2014 forward)


Earnings History for Abbott Laboratories (NYSE:ABT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/19/2016Q316$0.58$0.59$5.29 billion$5.30 billionViewListenView Earnings Details
7/20/2016Q216$0.53$0.55$5.24 billion$5.30 billionViewListenView Earnings Details
4/20/2016Q116$0.39$0.41$4.77 billion$4.90 billionViewListenView Earnings Details
1/28/2016Q415$0.61$0.62$5.31 billion$5.20 billionViewListenView Earnings Details
10/21/2015Q315$0.53$0.54$5.16 billion$5.15 billionViewListenView Earnings Details
7/22/2015Q215$0.50$0.52$5.15 billion$5.20 billionViewListenView Earnings Details
4/22/2015Q115$0.42$0.47$4.85 billion$4.90 billionViewListenView Earnings Details
1/29/2015Q414$0.69$0.71$5.48 billion$5.36 billionViewListenView Earnings Details
10/22/2014Q314$0.59$0.62$5.62 billion$5.10 billionViewListenView Earnings Details
7/16/2014Q214$0.51$0.54$5.53 billion$5.55 billionViewListenView Earnings Details
4/16/2014Q114$0.36$0.41$5.29 billion$5.24 billionViewListenView Earnings Details
1/22/2014Q413$0.58$0.58$5.72 billion$5.66 billionViewListenView Earnings Details
10/16/2013Q313$0.52$0.55$5.46 billion$5.37 billionViewListenView Earnings Details
7/17/2013Q2 2013$0.44$0.46$5.53 billion$5.45 billionViewListenView Earnings Details
4/17/2013Q1 2013$0.41$0.42$5.42 billion$5.38 billionViewListenView Earnings Details
1/23/2013Q4 2012$1.50$1.51$10.58 billion$10.80 billionViewListenView Earnings Details
10/17/2012$1.28$1.30ViewN/AView Earnings Details
7/18/2012$1.22$1.23ViewN/AView Earnings Details
4/18/2012$1.00$1.03ViewN/AView Earnings Details
1/25/2012$1.44$1.45ViewN/AView Earnings Details
10/19/2011$1.17$1.18ViewN/AView Earnings Details
7/20/2011$1.12$1.12ViewN/AView Earnings Details
4/20/2011$0.90$0.91ViewN/AView Earnings Details
1/26/2011$1.29$1.30ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Abbott Laboratories (NYSE:ABT)
Current Year EPS Consensus Estimate: $2.2 EPS
Next Year EPS Consensus Estimate: $2.45 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.39$0.40$0.39
Q2 20165$0.51$0.54$0.53
Q3 20163$0.58$0.60$0.59
Q4 20163$0.64$0.67$0.65
Q1 20172$0.46$0.50$0.48
Q2 20172$0.61$0.62$0.62
Q3 20172$0.64$0.66$0.65
Q4 20172$0.68$0.68$0.68
Q1 20181$0.51$0.51$0.51
(Data provided by Zacks Investment Research)


Current Dividend Information for Abbott Laboratories (NYSE:ABT)
Annual Dividend:$1.04
Dividend Yield:2.57%
Dividend Growth:-21.80% (3 Year Average)
Payout Ratio:114.29% (Based on Trailing 12 Months of Earnings)
47.27% (Based on Current Year Consensus EPS Estimate)
42.45% (Based on Next Year Consensus EPS Estimate)
Track Record:43 Years of Consecutive Dividend Growth

Dividend History for Abbott Laboratories (NYSE:ABT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Abbott Laboratories (NYSE:ABT)
Insider Ownership Percentage: 0.26%
Institutional Ownership Percentage: 73.00%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/26/2016Daniel Gesua Sive SalvadoriSVPSell815$41.71$33,993.65View SEC Filing  
7/28/2016Stephen R FussellInsiderSell41,500$45.00$1,867,500.00View SEC Filing  
7/26/2016Michael J WarmuthInsiderSell26,800$43.49$1,165,532.00View SEC Filing  
7/25/2016Miles D WhiteChairmanBuy242,547$43.18$10,473,179.46View SEC Filing  
7/25/2016Robert E FunckVPSell26,800$43.08$1,154,544.00View SEC Filing  
6/28/2016Hubert L AllenEVPSell3,400$37.14$126,276.00View SEC Filing  
6/15/2016Jared WatkinSVPSell552$37.63$20,771.76View SEC Filing  
6/1/2016Brian B YoorCFOSell565$39.49$22,311.85View SEC Filing  
4/28/2016Deepak S NathSVPSell53$41.31$2,189.43View SEC Filing  
3/31/2016Jaime ContrerasSVPSell462$41.78$19,302.36View SEC Filing  
2/29/2016Brian B YoorCFOSell865$39.12$33,838.80View SEC Filing  
2/29/2016Deepak S NathSVPSell793$39.27$31,141.11View SEC Filing  
2/29/2016Robert B FordEVPSell1,706$39.28$67,011.68View SEC Filing  
2/29/2016Robert E FunckVPSell1,333$39.30$52,386.90View SEC Filing  
2/22/2016Jared WatkinSVPSell554$39.09$21,655.86View SEC Filing  
2/16/2016Deepak S. NathSVPSell171$37.13$6,349.23View SEC Filing  
12/16/2015Miles D. WhiteCEOSell438,000$46.00$20,148,000.00View SEC Filing  
8/18/2015Stephen R. FussellEVPSell13,096$50.46$660,824.16View SEC Filing  
4/27/2015Heather L MasonEVPSell13,500$47.45$640,575.00View SEC Filing  
4/27/2015Roger BirdSVPSell28,548$47.57$1,358,028.36View SEC Filing  
3/26/2015J. Scott WhiteSVPSell12,483$46.68$582,706.44View SEC Filing  
3/2/2015Jaime ContrerasSVPSell9,209$47.34$435,954.06View SEC Filing  
2/4/2015John M CapekEVPSell34,292$45.66$1,565,772.72View SEC Filing  
11/25/2014Jaime ContrerasSVPSell51,600$44.07$2,274,012.00View SEC Filing  
10/29/2014Miles D WhiteCEOSell440,800$42.52$18,742,816.00View SEC Filing  
3/3/2014John LandgrafEVPSell17,293$39.38$680,998.34View SEC Filing  
3/3/2014Katherine DoyleSVPSell6,639$39.01$258,987.39View SEC Filing  
3/3/2014Robert FunckVPSell1,413$38.97$55,064.61View SEC Filing  
2/18/2014John LandgrafEVPSell1,583$39.10$61,895.30View SEC Filing  
1/29/2014Michael WarmuthEVPSell11,430$36.21$413,880.30View SEC Filing  
12/6/2013Jean-Yves PaveeSVPSell5,855$37.46$219,328.30View SEC Filing  
11/7/2013Stephen FussellEVPSell10,466$37.59$393,416.94View SEC Filing  
10/30/2013Jaime ContrerasSVPSell25,368$36.85$934,810.80View SEC Filing  
6/7/2013Heather L MasonSVPSell12,000$37.01$444,120.00View SEC Filing  
2/1/2013William A OsbornDirectorBuy10,000$33.86$338,600.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Abbott Laboratories (NYSE:ABT)
News IconAtlas Brown Inc. invests in Abbott Laboratories (ABT) Shares - DailyQuint (NYSE:ABT) - October 23 at 8:01 AM logoAbbott Laboratories (NYSE:ABT) Files An 8-K (NYSE:ABT) - October 22 at 8:34 AM
News IconAbbott Laboratories (NYSE:ABT) from Medical Appliances & Equipment – Todays Top Gains (NYSE:ABT) - October 22 at 8:34 AM
News IconHolder Worth Mentioning: As Abbott Laboratories (ABT) Share Value Declined, Holder Diamond Hill Capital ... - Chester News (NYSE:ABT) - October 21 at 8:19 PM logoTop Research Reports for Goldman Sachs, Verizon, Abbott & Others (NYSE:ABT) - October 21 at 3:16 PM logoAlere Shareholders Approve Merger With Abbott Labs (NYSE:ABT) - October 21 at 11:58 AM
News IconAbbott Laboratories (ABT) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS (NYSE:ABT) - October 21 at 11:58 AM
News IconAbbott Laboratories (NYSE:ABT) Insider Trading Update (NYSE:ABT) - October 21 at 11:58 AM logoCall Players Swarm Abbott Laboratories (ABT) On Muddy Waters' St. Jude Slam (NYSE:ABT) - October 21 at 11:58 AM logoAmid Headline Risk, Barclays Says St. Jude's Pipeline Underestimated - Benzinga (NYSE:ABT) - October 20 at 3:13 PM logoAbbott Laboratories (NYSE:ABT) Files An 8-K - Market Exclusive (NYSE:ABT) - October 20 at 3:13 PM logoPeople's Republic of China Clears Abbott Acquisition of Alere (NYSE:ABT) - October 20 at 3:13 PM
News IconAttractive Stock of Yesterday - Abbott Laboratories's (ABT) - Hot Stocks Point (NYSE:ABT) - October 20 at 8:11 AM logoAbbott Laboratories (ABT) volatility increases into Q3 and outlook - (NYSE:ABT) - October 20 at 8:11 AM logoAbbott Releases 3rd Quarter Results (NYSE:ABT) - October 20 at 8:11 AM logo[$$] Abbott Labs Swings to Loss After Booking Charge on Mylan Stake (NYSE:ABT) - October 20 at 8:11 AM logoWhy Intel Corporation (INTC), Rite Aid Corporation (RAD) and Abbott Laboratories (ABT) Are 3 of Today’s Worst Stocks (NYSE:ABT) - October 19 at 5:01 PM logoWhy Intel Corporation (INTC), Rite Aid Corporation (RAD) and Abbott Laboratories (ABT) Are 3 of Today’s Worst Stocks (NYSE:ABT) - October 19 at 5:00 PM logoFed Speakers And Beige Book, Bank Earnings, Rising Crude Take Center Stage - Benzinga (NYSE:ABT) - October 19 at 3:22 PM logoAbbott Laboratories Profit Advances 8% In Q3 - - Nasdaq (NYSE:ABT) - October 19 at 3:22 PM logoCall Players Swarm Abbott Laboratories (ABT) On Muddy Waters' St. Jude Slam - Schaeffers Research (blog) (NYSE:ABT) - October 19 at 3:22 PM logoAbbott Laboratories' (ABT) CEO Miles White on Q3 2016 Results ... - Seeking Alpha (NYSE:ABT) - October 19 at 3:22 PM logoAbbott Labs (ABT) Stock Up on Q3 Earnings Beat - (NYSE:ABT) - October 19 at 3:22 PM logoJim Cramer: Drug Stocks Feeling Political Pressure (NYSE:ABT) - October 19 at 3:22 PM logoAbbott Labs, St. Jude Lurch On Muddy Waters Tussle Despite Q3 Sales Beats (NYSE:ABT) - October 19 at 3:22 PM logoAbbott moves ahead on St. Jude, Alere deals, but investors fret (NYSE:ABT) - October 19 at 3:22 PM logoUPDATE 1-Abbott's third-quarter results edge past Street (NYSE:ABT) - October 19 at 9:10 AM logoAbbott's third-quarter revenue rises nearly 3 percent (NYSE:ABT) - October 19 at 8:10 AM logoSt. Jude Medical Q3 Bottom Line Number Misses - Benzinga (NYSE:ABT) - October 19 at 8:02 AM logoEarnings Reaction History: Abbott Laboratories, 44.4% Follow-Through Indicator, 2.5% Sensitive - Nasdaq (NYSE:ABT) - October 19 at 8:02 AM logoAbbott reports 3Q loss (NYSE:ABT) - October 19 at 8:02 AM logoAbbott Laboratories beats by $0.01, beats on revenue (NYSE:ABT) - October 19 at 7:49 AM logoEarnings Roll On, With Goldman, Netflix Results Giving Market A Lift - Benzinga (NYSE:ABT) - October 18 at 3:15 PM logoStocks Under Review: Exxon Mobil Corporation (XOM) Abbott Laboratories (ABT) Macy's, Inc. (M) - iStreetWire (NYSE:ABT) - October 18 at 3:15 PM logoAbbott Labs, St. Jude agree to sell assets for $1.1 billion after merger closes - MarketWatch (NYSE:ABT) - October 18 at 3:15 PM logoCincinnati firm to pay $28M to settle kickback claims (NYSE:ABT) - October 18 at 3:15 PM logoYour Two Minute Earnings Preview for Abbott Labs (ABT) Stock (NYSE:ABT) - October 18 at 3:15 PM logoAbbott, St. Jude Float Antitrust Spinoff by FTC (NYSE:ABT) - October 18 at 3:15 PM logoUPDATE 2-St. Jude and Abbott to sell some medical devices for $1.12 bln (NYSE:ABT) - October 18 at 11:57 AM logoSt. Jude and Abbott to sell some medical devices for $1.12 bln (NYSE:ABT) - October 18 at 9:21 AM logo[$$] St. Jude Medical Forms Cybersecurity Advisory Group (NYSE:ABT) - October 18 at 8:00 AM
News IconSpecial Reports for Abbott Laboratories (NYSE:ABT), Halliburton Company (NYSE:HAL), and Seagate Technology ... - Stock Traders Daily (NYSE:ABT) - October 17 at 3:15 PM logoTraders Watch list: Abbott Laboratories (ABT), Activision Blizzard, Inc. (ATVI), Mast Therapeutics, Inc. (MSTX) - iStreetWire (NYSE:ABT) - October 17 at 3:15 PM logoWhat to Look for When Abbott Labs (ABT) Reports Q3 Earnings - (NYSE:ABT) - October 17 at 3:15 PM logoAnalyzing Abbott Laboratories’ 3Q16 Revenue Estimates (NYSE:ABT) - October 17 at 3:15 PM logoWhat to Expect from Abbott Laboratories’ 3Q16 Earnings (NYSE:ABT) - October 17 at 3:15 PM logoWhat to Look for When Abbott Labs (ABT) Reports Q3 Earnings (NYSE:ABT) - October 17 at 3:15 PM logoPfizer Refuses to Go the Spinoff Route (NYSE:ABT) - October 17 at 3:15 PM
News IconLeading stocks in today’s market: Abbott Laboratories (NYSE:ABT) (NYSE:ABT) - October 16 at 8:02 AM
News IconIntraday Movers - Abbott Laboratories, (NYSE:ABT), Vipshop Holdings, (NYSE:VIPS) - Money News (NYSE:ABT) - October 15 at 3:13 PM


Abbott Laboratories (NYSE:ABT) Chart for Sunday, October, 23, 2016

Last Updated on 10/23/2016 by Staff